Our Team
The Organization
Mycotech Pharma is a subsidiary of parent company, ImmunoPharma, which has a long-standing history of successful product innovation with headquarters based in Norway. Mycotech is run by a core management team and guided by a world-wide advisory board and partnerships with researchers and scientists.
Core Management
Henning Fjøs, COO
Cand. mag. in mathematics and geophysics. Involved in numerous nutraceutical product developments. Played a leading role in the historical development of AndoSanâ„¢
Nicolai Flatner, CMO
Holds a Bachelor's degree in Business Administration from BI Norwegian Business School. With over 20 years of experience in the financial industry, he has served as a senior advisor and in sales management roles for prominent companies, including Zurich Insurance, Key Asset Management, and Skandinaviska Enskilda Banken (SEB).
Jennifer Furtmann, Supply Chain Manager
MSc from Distance Learning University in Germany. Previously worked as Global Supply Chain Manager for Evonik Industries, and Head of Supply and Demand Management in Kappa Bioscience
Elham Nikpey, CSO
Ph.D. in Biomedicine from the University of Bergen, along with an MSc in Medical Biology from Lund University in Sweden. Experience as a Researcher at Haukeland University Hospital, specializing in cardiovascular and circulation research. Additionally, worked as a management consultant and medical advisor for Eccelude and Pfizer.
Hiroyuki (Hiro) Tanaka, CEO Japan
Mr. Hiroyuki (Hiro) Tanaka, educated at the prestigious Keio University in Tokyo, has had an expansive career since entering Sumitomo Corporation in 2003, primarily in the food sector, including feed materials and grain processing businesses. He has been instrumental in export sales of vitamin K2 and has managed branches in Australia, China, and Vietnam. Further, he has spent several years with Sumitomo Corporation of America. With a keen interst in AndoSan, Mr. Hiro emphasizes the importance of a complete value chain in the food business to ensure quality and consistency.
Board of Directors
Christian Espeseth (Chairman)
Christian Espeseth has a solid background in the nutraceutical industry as well as the communications sector. With experience spanning various startups and larger growth companies, he can demonstrate success not only in his own ventures but also in projects for a wide range of industries, including FMCG, organizations, health, and nutraceuticals. He has extensive leadership experience at various levels within the communications industry, most recently as the CEO of dentsu X and the Growth Director for dentsu Norway. He possesses invaluable expertise in business development and growth, consistently delivering results. Throughout his professional career, he has maintained a focus on building teams that foster both unity and expansion. He excels in business strategy, concept/product development, organizational development, and, notably, culture and operationalization. He is known for his infectious enthusiasm and his ability to identify opportunities in almost any situation. Since 2018, he has served as the chairman of Eqology, which is owned by ImmunoPharma. During this period, the company has experienced significant growth. Christian holds a Master’s degree in Business and Marketing from BI (Norwegian Business School)
Scientific Advisory Board
Professor Geir Hetland
Professor Hetland conducts research at the Department of Immunology and Transfusion Medicine and the Department of Clinical Medicine at the Faculty of Medicine, Oslo University. Geir Hetland took an early interest in the potential of Andosan and has been a driving force in documenting the extract. He has devoted a large part of his research career to supervising four successful doctoral degrees based on Andosan research.
Dr. Bernd Fiebich
Specialist in cell biology. MD & PhD and 30 years of practical experience. CEO of Vivacell Biotechnology GmbH, a leading biological consultancy for natural components.
Scientific Partnerships
